Reynoso Jamie L. 4

What Happened
Jamie L. Reynoso, CEO (Medicare Advantage) of Clover Health Investments, Inc. (CLOV), was awarded 159,384 restricted stock units (RSUs) on April 1, 2026. The award is reported as an acquisition (code A) at $0.00 per share — i.e., RSUs representing Class A common stock rather than an open‑market purchase; no immediate cash value is recorded in the filing.

Key Details

• Transaction date: 2026-04-01; Form 4 filed: 2026-04-03 (filed within the typical 2-business-day deadline).
• Transaction type: Award/Grant (RSUs), 159,384 units; acquisition price reported $0.00.
• Vesting: 25% vests on April 1, 2027; remaining RSUs vest in 12 equal quarterly installments starting three months after the first anniversary; fully vested on April 1, 2030, subject to continued service.
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Footnote: Awarded RSUs convert to Class A common shares upon vesting (see vesting schedule above).

Context
RSUs are compensation that convert into shares over time if the executive remains employed; they do not constitute an immediate market purchase or sale. Such grants are common for aligning executive incentives with shareholder value but are not a direct indicator of immediate insider buying or selling intent.